Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?
Acrivon Therapeutics Ownership Summary
Acrivon Therapeutics is owned by 1.70% institutional investors, 20.64% insiders, and 77.66% retail investors. Ra capital management is the largest institutional shareholder, holding 21.69% of ACRV shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.68% of its assets in Acrivon Therapeutics shares.
ACRV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acrivon Therapeutics | 1.70% | 20.64% | 77.66% |
| Sector | Healthcare Stocks | 42.52% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.18% | 10.75% | 44.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 8.34M | 21.69% | $15.10M |
| Sands capital ventures | 2.12M | 5.52% | $3.84M |
| Wellington management group llp | 888.13K | 2.31% | $1.61M |
| Ubs group | 683.22K | 1.78% | $1.24M |
| Vanguard group | 626.15K | 1.63% | $1.13M |
| Renaissance | 623.40K | 1.62% | $1.13M |
| Acorn capital advisors | 405.24K | 1.05% | $733.48K |
| Blackrock funding, inc. /de | 330.96K | 0.86% | $599.03K |
| Two sigma investments, lp | 319.20K | 0.83% | $577.76K |
| Jane street group | 289.25K | 0.75% | $523.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sands capital ventures | 2.12M | 0.84% | $3.84M |
| Acorn capital advisors | 405.24K | 0.37% | $733.48K |
| Ra capital management | 8.34M | 0.19% | $15.10M |
| Aaf wealth management | 10.68K | 0.01% | $19.33K |
| Xtx topco | 35.95K | 0.00% | $65.08K |
| Colony group | 19.85K | 0.00% | $987.93K |
| Renaissance | 623.40K | 0.00% | $1.13M |
| Algert global | 44.65K | 0.00% | $81.00K |
| Two sigma investments, lp | 319.20K | 0.00% | $577.76K |
| Bridgeway capital management | 22.90K | 0.00% | $41.45K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 683.22K | 0.00% | 682.76K |
| Two sigma investments, lp | 319.20K | 0.00% | 138.03K |
| Renaissance | 623.40K | 0.00% | 114.11K |
| Two sigma advisers, lp | 136.50K | 0.00% | 103.90K |
| Acadian asset management | 92.00K | 0.00% | 92.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -5.36M |
| Hrt financial lp | - | - | -145.90K |
| Goldman sachs group | 19.74K | - | -120.31K |
| Dafna capital management | - | - | -112.41K |
| Blackrock funding, inc. /de | 330.96K | - | -76.67K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Acadian asset management | 92.00K | 0.00% | 92.00K | $165.00K |
| Algert global | 44.65K | 0.00% | 44.65K | $81.00K |
| Colony group | 19.85K | 0.00% | 19.85K | $987.93K |
| Eversource wealth advisors | 373.00 | - | 373.00 | $675.00 |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -141.00 |
| True wealth design | -176.00 |
| Sterling capital management | -198.00 |
| Gamma investing | -287.00 |
| Amalgamated bank | -378.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 10 | -80.77% | 655,031 | -96.32% | 1 | 0.08% | 5 | -80.77% | 3 | -81.25% |
| Jun 30, 2025 | 51 | -15.00% | 17,796,335 | -20.97% | 46 | 1.34% | 25 | 4.17% | 16 | -23.81% |
| Mar 31, 2025 | 4 | -93.10% | 14,129,412 | -38.60% | 36 | 1.01% | - | -100.00% | 1 | -92.86% |
| Dec 31, 2024 | 59 | 15.69% | 23,249,551 | 1.26% | 61 | 1.68% | 31 | 29.17% | 14 | - |
| Sep 30, 2024 | 51 | - | 22,960,755 | -2.09% | 60 | 1.43% | 24 | -31.43% | 14 | 133.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 527.15K | 1.68% | -39.51K |
| Vanguard Total Stock Mkt Idx Inv | 403.61K | 1.28% | -8.82K |
| Vanguard US Total Market Shares ETF | 387.41K | 1.24% | - |
| Fidelity Small Cap Index | 129.48K | 0.41% | - |
| iShares Biotechnology ETF | 125.85K | 0.40% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 121.16K | 0.39% | -55.21K |
| iShares Russell 2000 Value ETF | 108.94K | 0.35% | - |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 84.78K | 0.27% | 30.72K |
| Fidelity Extended Market Index | 73.47K | 0.23% | -605.00 |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 64.10K | 0.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 01, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $400.51K |
| Apr 30, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $617.41K |
| Apr 29, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $352.50K |
| Apr 25, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $2.06M |
| Apr 28, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $335.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
ACRV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools